Marta Borghi

1.1k total citations
45 papers, 579 citations indexed

About

Marta Borghi is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Marta Borghi has authored 45 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 40 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Marta Borghi's work include Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis B Virus Studies (24 papers). Marta Borghi is often cited by papers focused on Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis B Virus Studies (24 papers). Marta Borghi collaborates with scholars based in Italy, Germany and Singapore. Marta Borghi's co-authors include Pietro Lampertico, Elisabetta Degasperi, Roberta D’Ambrosio, Riccardo Perbellini, R. Soffredini, Angelo Sangiovanni, Massimo Iavarone, Alessandro Loglio, G. Lunghi and F. Facchetti and has published in prestigious journals such as PLoS ONE, Hepatology and PEDIATRICS.

In The Last Decade

Marta Borghi

42 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Borghi Italy	14	485	442	53	29	28	45	579
Valérie Oulès France	12	327 0.7×	344 0.8×	33 0.6×	17 0.6×	33 1.2×	25	439
Shun Kaneko Japan	14	522 1.1×	524 1.2×	62 1.2×	17 0.6×	44 1.6×	55	695
Hannah M. Lee United States	11	286 0.6×	254 0.6×	69 1.3×	24 0.8×	43 1.5×	24	405
Jui-Ting Hu Taiwan	8	382 0.8×	325 0.7×	22 0.4×	28 1.0×	17 0.6×	10	417
Yuqiang Mi China	11	356 0.7×	223 0.5×	69 1.3×	20 0.7×	30 1.1×	50	474
Christoph Antoni Germany	10	269 0.6×	240 0.5×	49 0.9×	30 1.0×	32 1.1×	32	405
Simin Guo China	13	387 0.8×	280 0.6×	55 1.0×	105 3.6×	30 1.1×	37	574
Wiesław Kryczka Poland	12	483 1.0×	479 1.1×	106 2.0×	35 1.2×	51 1.8×	34	651
Eiji Tanaka Japan	8	314 0.6×	240 0.5×	58 1.1×	17 0.6×	22 0.8×	10	431
Sujan Ravi United States	8	277 0.6×	233 0.5×	59 1.1×	16 0.6×	12 0.4×	18	402

Countries citing papers authored by Marta Borghi

Since Specialization

Citations

This map shows the geographic impact of Marta Borghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Borghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Borghi more than expected).

Fields of papers citing papers by Marta Borghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Borghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Borghi. The network helps show where Marta Borghi may publish in the future.

Co-authorship network of co-authors of Marta Borghi

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Borghi. A scholar is included among the top collaborators of Marta Borghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Borghi. Marta Borghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salpini, Romina, Elisabetta Degasperi, Lorenzo Piermatteo, et al.. (2025). HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D. Liver International. 45(5). e70094–e70094.

Renteria, Sara Uceda, Elisabetta Degasperi, Marta Borghi, et al.. (2024). Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods. Liver International. 44(3). 831–837. 4 indexed citations

Toniutto, Pierluigi, Edmondo Falleti, Sara Cmet, et al.. (2024). Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide. Journal of Hepatology. 81(5). 819–826. 5 indexed citations

Renteria, Sara Uceda, Elisabetta Degasperi, F. Facchetti, et al.. (2024). Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV. JHEP Reports. 7(3). 101299–101299. 3 indexed citations

Salpini, Romina, Elisabetta Degasperi, Lorenzo Piermatteo, et al.. (2024). WED-399-YI The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks. Journal of Hepatology. 80. S798–S798. 1 indexed citations

Degasperi, Elisabetta, Sara Uceda Renteria, Marta Borghi, et al.. (2023). Pretreatment and on-therapy HDV RNA levels predict response to Bulevirtide monotherapy in HDV compensated cirrhotic patients treated up to 96 weeks. Journal of Hepatology. 78. S1159–S1159. 1 indexed citations

Tonon, Marta, Roberta D’Ambrosio, Valeria Calvino, et al.. (2023). A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis. Journal of Hepatology. 80(4). 603–609. 18 indexed citations

Degasperi, Elisabetta, Sara Uceda Renteria, Marta Borghi, et al.. (2022). Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension. Journal of Hepatology. 77(6). 1525–1531. 42 indexed citations

Shekhtman, Louis, Harel Dahari, Scott J. Cotler, et al.. (2022). Most patients with advanced cirrhosis treated with bulevirtide monotherapy have a non-monophasic HDV RNA decline patterns: an interim kinetic analysis of real-life setting. Journal of Hepatology. 77. S874–S874. 1 indexed citations

10.

D’Ambrosio, Roberta, Elisabetta Degasperi, Marta Borghi, et al.. (2021). Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR. Journal of Hepatology. 76(2). 302–310. 49 indexed citations

11.

D’Ambrosio, Roberta, Irene Campi, Marco Maggioni, et al.. (2021). The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). PLoS ONE. 16(4). e0249614–e0249614. 19 indexed citations

12.

Loglio, Alessandro, Péter Ferenci, Sara Uceda Renteria, et al.. (2021). Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis. Journal of Hepatology. 76(2). 464–469. 48 indexed citations

13.

Tham, C, Janine Kah, Anthony T. Tan, et al.. (2020). Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes. Cell Reports Medicine. 1(4). 100060–100060. 21 indexed citations

14.

Acerbi, Greta, Ilaria Montali, Valeria Barili, et al.. (2020). Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B. Journal of Hepatology. 74(4). 783–793. 38 indexed citations

15.

Loglio, Alessandro, Péter Ferenci, Sara Uceda Renteria, et al.. (2019). Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients. Journal of Hepatology. 71(4). 834–839. 47 indexed citations

16.

Degasperi, Elisabetta, E. Galmozzi, F. Facchetti, et al.. (2019). Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients. Digestive and Liver Disease. 51. e67–e67. 1 indexed citations

17.

Degasperi, Elisabetta, Roberta D’Ambrosio, Massimo Iavarone, et al.. (2018). Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection. Clinical Gastroenterology and Hepatology. 17(6). 1183–1191.e7. 83 indexed citations

18.

Grossi, G., Alessandro Loglio, F. Facchetti, et al.. (2017). Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance. Journal of Hepatology. 68(1). 195–198. 21 indexed citations

19.

Clavenna, Antonio, Marco Sequi, Massimo Cartabia, et al.. (2014). Effectiveness of Nebulized Beclomethasone in Preventing Viral Wheezing: An RCT. PEDIATRICS. 133(3). e505–e512. 13 indexed citations

20.

Cretich, Marina, Daniela Breda, Francesco Damin, et al.. (2010). Allergen microarrays on high-sensitivity silicon slides. Analytical and Bioanalytical Chemistry. 398(4). 1723–1733. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact